Nouf Aljobaily, Denise Allard, Bryant Perkins, Arielle Raugh, Tessa Galland, Yi Jing, W. Zac Stephens, Matthew L. Bettini, J. Scott Hale, Maria Bettini
{"title":"Autoimmune CD4+ T cells fine-tune TCF1 expression to maintain function and survive persistent antigen exposure during diabetes","authors":"Nouf Aljobaily, Denise Allard, Bryant Perkins, Arielle Raugh, Tessa Galland, Yi Jing, W. Zac Stephens, Matthew L. Bettini, J. Scott Hale, Maria Bettini","doi":"10.1016/j.immuni.2024.09.016","DOIUrl":null,"url":null,"abstract":"Self-reactive T cells experience chronic antigen exposure but do not exhibit signs of exhaustion. Here, we investigated the mechanisms for sustained, functioning autoimmune CD4<sup>+</sup> T cells despite chronic stimulation. Examination of T cell priming showed that CD4<sup>+</sup> T cells activated in the absence of infectious signals retained TCF1 expression. At later time points and during blockade of new T cell recruitment, most islet-infiltrating autoimmune CD4<sup>+</sup> T cells were TCF1<sup>+</sup>, although expression was reduced on a per T cell basis. The <em>Tcf7</em> locus was epigenetically modified in circulating autoimmune CD4<sup>+</sup> T cells, suggesting a pre-programmed <em>de novo</em> methylation of the locus in early stages of autoimmune CD4<sup>+</sup> T cell differentiation. This mirrored the epigenetic profile of recently recruited CD4<sup>+</sup>CD62L<sup>+</sup> T cells in the pancreas. Collectively, these data reveal a unique environment during autoimmune CD4<sup>+</sup> T cell priming that allows T cells to fine-tune TCF1 expression and maintain long-term survival and function.","PeriodicalId":13269,"journal":{"name":"Immunity","volume":"13 1","pages":""},"PeriodicalIF":25.5000,"publicationDate":"2024-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunity","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.immuni.2024.09.016","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Self-reactive T cells experience chronic antigen exposure but do not exhibit signs of exhaustion. Here, we investigated the mechanisms for sustained, functioning autoimmune CD4+ T cells despite chronic stimulation. Examination of T cell priming showed that CD4+ T cells activated in the absence of infectious signals retained TCF1 expression. At later time points and during blockade of new T cell recruitment, most islet-infiltrating autoimmune CD4+ T cells were TCF1+, although expression was reduced on a per T cell basis. The Tcf7 locus was epigenetically modified in circulating autoimmune CD4+ T cells, suggesting a pre-programmed de novo methylation of the locus in early stages of autoimmune CD4+ T cell differentiation. This mirrored the epigenetic profile of recently recruited CD4+CD62L+ T cells in the pancreas. Collectively, these data reveal a unique environment during autoimmune CD4+ T cell priming that allows T cells to fine-tune TCF1 expression and maintain long-term survival and function.
自身免疫性 CD4+ T 细胞对 TCF1 的表达进行微调,以维持功能并在糖尿病期间持续接触抗原后存活下来
自我反应 T 细胞会长期暴露于抗原,但不会表现出衰竭的迹象。在这里,我们研究了自身免疫 CD4+ T 细胞在长期刺激下仍能持续发挥作用的机制。对 T 细胞引物的研究表明,在没有感染信号的情况下激活的 CD4+ T 细胞保留了 TCF1 的表达。在较晚的时间点和阻断新T细胞招募期间,大多数小岛浸润的自身免疫CD4+ T细胞都是TCF1+,尽管每个T细胞的表达量减少了。在循环的自身免疫 CD4+ T 细胞中,Tcf7 基因座发生了表观遗传学改变,这表明在自身免疫 CD4+ T 细胞分化的早期阶段,该基因座发生了预编程的从头甲基化。这反映了胰腺中最近招募的 CD4+CD62L+ T 细胞的表观遗传学特征。总之,这些数据揭示了自身免疫 CD4+ T 细胞初始化过程中的独特环境,它允许 T 细胞微调 TCF1 的表达并维持长期存活和功能。
期刊介绍:
Immunity is a publication that focuses on publishing significant advancements in research related to immunology. We encourage the submission of studies that offer groundbreaking immunological discoveries, whether at the molecular, cellular, or whole organism level. Topics of interest encompass a wide range, such as cancer, infectious diseases, neuroimmunology, autoimmune diseases, allergies, mucosal immunity, metabolic diseases, and homeostasis.